TY - JOUR
T1 - Chronic intake of high fish oil diet induces myeloid-derived suppressor cells to promote tumor growth
AU - Xia, Sheng
AU - Li, Xiaoping
AU - Cheng, Lu
AU - Han, Mutian
AU - Zhang, Miaomiao
AU - Liu, Xia
AU - Xu, Huaxi
AU - Zhang, Minghui
AU - Shao, Qixiang
AU - Qi, Ling
N1 - Funding Information:
Acknowledgments this work was funded by grants from the national natural Science Foundation of China 81172834 and 31200676, the project sponsored by the Scientific research Foundation for the returned Overseas Chinese Scholars, State education Ministry and Jiangsu University Faculty Initiation Funding 08JDg044 (to Sheng Xia.) and national Institutes of Health r01DK082582 and american Diabetes association 1-12-CD-04 (to ling Qi). thanks other members of the Qi and Xia laboratories for helpful discussion.
PY - 2014/7
Y1 - 2014/7
N2 - Omega-3 polyunsaturated fatty acids enriched fish oil exerts beneficial anti-inflammatory effects in animal models with acute and chronic inflammatory diseases. Myeloid-derived suppressor cells (MDSCs), comprised of myeloid progenitors and precursors of myeloid cells, play vital roles in cancer. How fish oil affects the generation of MDSCs and the tumor development remains largely unexplored. Here, we show that dietary intake of high fish oil diet suppresses CD8+ T cells activation and proliferation in vivo via elevated levels of MDSCs. Mechanistically, high fish oil diet induces the expression of immunosuppressive cytokine IL-10 and promotes myelopoiesis in the spleen as well as other peripheral tissues. The immature myeloid cells in the spleen exhibit morphological and functional characteristics of MDSCs with the capability to downregulate CD8+ T cells activation. Depletion of MDSCs using anti-Gr-1 antibody decreases the growth of subcutaneously transferred B16 melanoma in mice on high fish oil diet. Interestingly, diet-induced production of MDSCs is not solely dependent of the spleen, as splenectomy has no effect on the tumor progress. Our data show that the liver functions as an alternative extramedullary hematopoiesis organ to support MDSCs differentiation and maintain tumor growth. Taken together, our study provides a novel insight into the physiological effects of fish oil and points to MDSCs as a possible mediator linking dietary fish oil intake and immunosuppression in cancer immunosurveillance.
AB - Omega-3 polyunsaturated fatty acids enriched fish oil exerts beneficial anti-inflammatory effects in animal models with acute and chronic inflammatory diseases. Myeloid-derived suppressor cells (MDSCs), comprised of myeloid progenitors and precursors of myeloid cells, play vital roles in cancer. How fish oil affects the generation of MDSCs and the tumor development remains largely unexplored. Here, we show that dietary intake of high fish oil diet suppresses CD8+ T cells activation and proliferation in vivo via elevated levels of MDSCs. Mechanistically, high fish oil diet induces the expression of immunosuppressive cytokine IL-10 and promotes myelopoiesis in the spleen as well as other peripheral tissues. The immature myeloid cells in the spleen exhibit morphological and functional characteristics of MDSCs with the capability to downregulate CD8+ T cells activation. Depletion of MDSCs using anti-Gr-1 antibody decreases the growth of subcutaneously transferred B16 melanoma in mice on high fish oil diet. Interestingly, diet-induced production of MDSCs is not solely dependent of the spleen, as splenectomy has no effect on the tumor progress. Our data show that the liver functions as an alternative extramedullary hematopoiesis organ to support MDSCs differentiation and maintain tumor growth. Taken together, our study provides a novel insight into the physiological effects of fish oil and points to MDSCs as a possible mediator linking dietary fish oil intake and immunosuppression in cancer immunosurveillance.
KW - Cancer
KW - Fish oil
KW - Liver
KW - MDSCs
KW - Polyunsaturated fatty acids
UR - https://www.scopus.com/pages/publications/84903817899
U2 - 10.1007/s00262-014-1546-7
DO - 10.1007/s00262-014-1546-7
M3 - Article
C2 - 24691944
AN - SCOPUS:84903817899
SN - 0340-7004
VL - 63
SP - 663
EP - 673
JO - Cancer Immunology, Immunotherapy
JF - Cancer Immunology, Immunotherapy
IS - 7
ER -